Multiple sclerosis (MS) drug pulled from market after reports of brain inflammation

Fibromyalgia Linked to Overactive Brain Networks

In a rare move, the companies that make the multiple sclerosis drug daclizumab (brand name Zinbryta) have voluntarily pulled the medication from the market and stopped all clinical studies after reports of eight cases of serious brain inflammation among patients in Europe.

Manufacturers Biogen and AbbVie acted on the same day the European Medicines Agency called for an “urgent review” of the multiple sclerosis medicine.

Seven patients in Germany and one in Spain presented with encephalitis and or meningoencephalitis, which are both inflammation of the brain.

Read the full article here.

One thought on “Multiple sclerosis (MS) drug pulled from market after reports of brain inflammation

  1. I was diagnosed with multiple sclerosis 1 month after I turned 45. My grandma is 96 and had it since she was in her 20s. I have been on Copaxone, the first year was daily and now I am on 40 mg, 3 times a week. It made a tremendous difference for me. Although the fatigue is what really gets to me. When I do too much, I do start to feel weak. My MS got significantly worse and unbearable Last year, a family friend told me about Organic Herbal clinic and their successful MS TREATMENT, I visited their website ww w . organicherbalclinic. co m and ordered their MS Formula, i am happy to report the treatment effectively treated and reversed my Multiple Sclerosis(MS)), most of the symptoms stopped, I’m able to walk and eat well, sleep well and exercise regularly., I’m pretty active now and my attitude is extremely positive.

Leave a Reply

Your email address will not be published. Required fields are marked *